Page 5 - Best hematologist-oncologists: TOP 171 doctors

Prof. Celal Acar specializes in hematology and oncology at Medicalpoint International Hospital, with a focus on complex internal medicine cases.

• Trained in hematology at Dokuz Eylül University
• Experienced in treating joint swelling and kidney-related conditions
• Handles diverticular bowel disease and liver abscess cases

Specialist in radiotherapy for oncology, focusing on treating cancer patients with radiation at Rambam Medical Center.

• Specializes in using radiotherapy to treat cancers, including lymphoma and leukemia
• Combines expertise in both radiation and medical oncology for patient care
• Focuses on personalized treatment plans for Hodgkin's lymphoma
• Uses advanced radiotherapy techniques for precise cancer treatment

Dr. Nivit Karla brings extensive training in internal medicine and cardiology to hematology oncology care at PrimeCare Bkk.

• Trained at Siriraj Medical School – one of Thailand's top institutions
• Specializes in integrating cardiology insights into oncology care
• Fluent in both English and Thai for clear patient communication

Dr. Emiroglu specializes in oncoplastic breast surgery, offering advanced techniques for better aesthetic and functional outcomes.

• Trained in breast surgery techniques at Europe Senology Academia
• Member of the Breast Surgery Association and Endocrine Surgery Association
• Over 29 years of experience of experience in general surgery
• Works at Memorial Bodrum Hospital, a leading healthcare facility

Pioneer in using interferon for MPNs since the 1980s, Prof. Gisslinger is a top hematologist at the Medical University of Vienna.

• 41 years of experience developing treatments for myeloproliferative neoplasms
• Founder of the Laboratory for Myeloproliferative Neoplasms
• Specializes in polycythemia vera, essential thrombocythemia, and myelofibrosis
• Program Director for Myeloproliferative Neoplasms research

Specializes exclusively in hematology with a focus on treating lymphomas at Rambam Medical Center – Israel's largest hospital.

• Expertise in Hodgkin's lymphoma and lymphoproliferative diseases
• Provides targeted treatments for various lymphoma subtypes
• Works at a leading tertiary care and research hospital
• Dedicated to personalized treatment plans for lymphoma patients

Deputy head of the Pediatric Hematology Department at Rambam Medical Center – specializes in pediatric blood disorders and cancers.

• of experience in pediatric hematology
• Focuses on treating childhood leukemias and lymphomas
• Participates in research for innovative pediatric treatments
• Works within one of Israel's leading medical centers

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

 Mali interdisciplinary hospital is integrating conventional, regenerative and precision medicine. It divides into 11 departments, there are 35 beds in total, including 12 intensive care beds, 23 general beds, 2 emergency and operating rooms, 1 plastic surgical room, 1 Gastro-colonoscopic room. Focus on round-trip treatment with modern medical technology to reduce the cost of hospitalization and the healing time. It also integrating regenerative medicine to repair the body and precision medicine for preventing and treating chronic non-communicable diseases (NCDs) with better results, we provide these services in a greenery atmosphere. Allowing clients to receive the following benefits.

1. Far away from NCDs & It’s complication

2. Good quality of life

3. Youthful lively life

4. Longevity

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

80+ active clinical trials in CLL – Prof. Bosch leads groundbreaking research at Hospital Quiron Barcelona to advance lymphoma treatments worldwide.

• World-renowned leader in Chronic Lymphocytic Leukemia and lymphomas
• Heads Hematology at Vall d'Hebron University Hospital and IOB Institute of Oncology
• Published over 100 studies in top journals like NEJM and Nature Medicine
• President of the Spanish CLL research group (GELLC)
• Trained at Columbia University's Institute of Cancer Genetics

Prof. Keun Chil Park heads the Division of Hematology-Oncology at Samsung Medical Center, specializing in lung, head and neck, and esophageal cancers.

• Graduated from Seoul National University College of Medicine
• Member of prestigious oncology associations including ASCO and ESMO
• Focuses on hematology-oncology with extensive experience in the field
• Active in international cancer research communities